Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Exact Sciences Corporation EXAS | VANGUARD GROUP INC | 17,252,465 9.710% | 1,820,731 (+11.80%) | Filing History |
| 2023-02-07 10:43 am Purchase | 2022-12-31 | 13G | Exact Sciences Corporation EXAS | BlackRock Inc. BLK | 11,354,134 6.400% | 1,857,122 (+19.55%) | Filing History |
| 2023-02-06 2:51 pm Sale | 2022-12-30 | 13G | Exact Sciences Corporation EXAS | Wellington Management Group LLP | 10,404,476 5.860% | -720,921 (-6.48%) | Filing History |
| 2022-09-12 2:07 pm Sale | 2022-08-31 | 13G | Exact Sciences Corporation EXAS | T. Rowe Price Associates, Inc. | 6,464,337 3.700% | -12,260,399 (-65.48%) | Filing History |
| 2022-03-10 12:48 pm Purchase | 2022-02-28 | 13G | Exact Sciences Corporation EXAS | T. Rowe Price Associates, Inc. | 18,724,736 10.700% | 4,936,603 (+35.80%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | T. Rowe Price Associates, Inc. | 13,788,133 8.000% | -2,764,957 (-16.70%) | Filing History |
| 2022-02-11 2:48 pm Sale | 2022-02-14 | 13G | Exact Sciences Corporation EXAS | Capital World Investors | 4,682,850 2.700% | -5,615,546 (-54.53%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | VANGUARD GROUP INC | 15,431,734 8.960% | 1,231,641 (+8.67%) | Filing History |
| 2022-02-09 12:25 pm Purchase | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | ARK Investment Management LLC | 13,496,014 7.830% | 13,496,014 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | BlackRock Inc. BLK | 9,497,012 5.500% | 1,208,534 (+14.58%) | Filing History |
| 2022-02-04 09:17 am Purchase | 2021-12-31 | 13G | Exact Sciences Corporation EXAS | Wellington Management Group LLP | 11,125,397 6.450% | 5,302,791 (+91.07%) | Filing History |
| 2021-02-16 12:34 pm Purchase | 2021-02-16 | 13G | Exact Sciences Corporation EXAS | Capital World Investors | 10,298,396 6.500% | 10,298,396 (New Position) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Exact Sciences Corporation EXAS | T. Rowe Price Associates, Inc. | 16,553,090 10.400% | -2,145,501 (-11.47%) | Filing History |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Exact Sciences Corporation EXAS | VANGUARD GROUP INC | 14,200,093 8.930% | 771,989 (+5.75%) | Filing History |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Exact Sciences Corporation EXAS | BlackRock Inc. BLK | 8,288,478 5.200% | 501,836 (+6.44%) | Filing History |